Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-511820-15-03Phase 4Completed
Phase 4, randomised trial of diclofenac and lisinopril + hydrochlorothiazide in open-angle glaucoma (OAG), pseudoexfoliation glaucoma (PXG), pigmentary glaucoma (PG) and 1 more (3 arms), sponsored by Rigshospitalet. Primary endpoint: Intraocular pressure at 12 months. Started Nov 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-511820-15-03.